These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1768484)

  • 21. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF; Swain GW; Mangi AA
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation.
    Jessup M; Albert NM; Lanfear DE; Lindenfeld J; Massie BM; Walsh MN; Zucker MJ; ; ;
    J Card Fail; 2011 May; 17(5):349-58. PubMed ID: 21549290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart transplantation versus continuous-flow left ventricular assist device: comprehensive cost at 1 year.
    Patel SR; Sileo A; Bello R; Gunda S; Nguyen J; Goldstein D
    J Card Fail; 2015 Feb; 21(2):160-6. PubMed ID: 25433361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of ventricular assist devices: can we afford the progress?
    Miller LW; Guglin M; Rogers J
    Circulation; 2013 Feb; 127(6):743-8. PubMed ID: 23401115
    [No Abstract]   [Full Text] [Related]  

  • 27. [A heart-assist device. A life-saving mechanical circulatory support to be used while waiting for heart transplantation].
    Jansson K; Casimir-Ahn H; Lönn U; Nylander E; Peterzén B; Dahlström U
    Lakartidningen; 1995 Sep; 92(38):3437-8, 3443-4. PubMed ID: 7564577
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.
    Hutchinson J; Scott DA; Clegg AJ; Loveman E; Royle P; Bryant J; Colquitt JL
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):175-85. PubMed ID: 18248272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the proposed memo on the national coverage decision for durable mechanical circulatory support device therapy.
    Pagani FD
    Artif Organs; 2020 Dec; 44(12):1248-1250. PubMed ID: 33263193
    [No Abstract]   [Full Text] [Related]  

  • 31. Left ventricular assist devices as permanent heart failure therapy: the price of progress.
    Oz MC; Gelijns AC; Miller L; Wang C; Nickens P; Arons R; Aaronson K; Richenbacher W; van Meter C; Nelson K; Weinberg A; Watson J; Rose EA; Moskowitz AJ
    Ann Surg; 2003 Oct; 238(4):577-83; discussion 583-5. PubMed ID: 14530729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor vehicle safety, health care, and taxes. National Highway Traffic Safety Administration, U.S. Department of Transportation.
    Prehosp Disaster Med; 1994; 9(1):11-23. PubMed ID: 10155483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Session IX: Social and ethical controversies in pediatric heart transplantation.
    Ashwal S; Caplan AL; Cheatham WA; Evans RW; Peabody JL; Larson D
    J Heart Lung Transplant; 1991; 10(5 Pt 2):860-76. PubMed ID: 1742298
    [No Abstract]   [Full Text] [Related]  

  • 34. Hope in our hearts.
    Nelson HL
    Hastings Cent Rep; 1994; 24(1):2-3. PubMed ID: 8045763
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethics of the heart: ethical and policy challenges in the treatment of advanced heart failure.
    Fields AV; Kirkpatrick JN
    Perspect Biol Med; 2012; 55(1):71-80. PubMed ID: 22643717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America.
    Jessup M; Albert NM; Lanfear DE; Lindenfeld J; Massie BM; Walsh MN; Zucker MJ
    Circ Heart Fail; 2011 May; 4(3):378-87. PubMed ID: 21464151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an inexpensive blue band during ventricular assist device and total artificial heart placement facilitates and expedites explantation during heart transplant.
    Jaroszewski DE; Lackey JJ; Lanza LA; DeValeria PA; Arabia FA
    Ann Thorac Surg; 2009 May; 87(5):1623-4. PubMed ID: 19379933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economic costs of pain in the United States.
    Gaskin DJ; Richard P
    J Pain; 2012 Aug; 13(8):715-24. PubMed ID: 22607834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical circulatory support systems--a review.
    Mihaylov D; Verkerke GJ; Rakhorst G
    Technol Health Care; 2000; 8(5):251-66. PubMed ID: 11204171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economic burden of chronic cardiovascular disease for major insurers.
    Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
    Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.